ArticleOncotarget2017

Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibition.

Bingjie Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.